QuamCore

High-Level Overview

QuamCore is an Israeli deep-tech startup founded in 2022, specializing in superconducting quantum computing hardware to enable scalable systems with up to 1 million qubits in a single cryostat.[1][2][4][6] The company develops a patented processor architecture that integrates ultra-low-power digital superconducting control logic directly alongside qubits at cryogenic temperatures (as low as 10mK), solving key scalability challenges like wiring density, heat load, thermal bottlenecks, and error correction.[3][4][5][6] It serves research institutions, pharmaceuticals, AI, materials science, and energy sectors by providing fault-tolerant quantum systems that reduce power consumption, size, and costs compared to traditional designs.[1][2][4] QuamCore emerged from stealth in March 2025 with $9M seed funding (led by Viola Ventures and Earth & Beyond), followed by a $26M Series A in August 2025, totaling $35M to fund fabrication and lab setup, showing strong early momentum.[2][4][6]

Origin Story

QuamCore was founded in 2022 in Herzliya, Israel, after 2.5 years of stealth development on a novel superconducting quantum processor architecture.[1][2][4] The idea emerged from the need to address quantum computing's core scaling problem—making large-scale systems practical and economical—by rethinking superconducting qubits, the most mature platform.[2][6] CEO and co-founder Alon Cohen, an IDF Unit 8200 alumnus with 25+ years in intelligence systems, communication chips, and radar (co-founder of EyeC Radar at Mobileye/Intel, holder of 40+ patents, Intel Oscar Prize winner), leads operations.[2][4] Chief Scientist Prof. Serge Rosenblum (Weizmann Institute) brings 15+ years in quantum technologies with publications in *Science*.[2] CTO Prof. Shay Cohen-Georgi and senior advisor Prof. Ivey Friedman (University of Rochester) provide expertise in superconductors and chip design.[1] Early traction included $9M seed from Viola Ventures, Surround Ventures, Axess Ventures, Qbeat Ventures, Earth & Beyond, Rhodium, and Israel Innovation Authority, fueling the public unveiling.[1][2]

Core Differentiators

QuamCore stands out in quantum computing through its architecture-first approach to superconducting systems:

• Million-Qubit Scalability in One Cryostat: Patented design integrates digital SFQ (Superconducting Flux Quantum) control logic directly with qubits, slashing cabling by orders of magnitude, eliminating thermal limits, and fitting 1M qubits into chip-sized space—previously impossible.[2][4][5][6]
• Built-in Error Correction and Low Power: Error-correction-aware architecture with ultra-low dissipation at 10mK reduces computational errors, power use, and costs versus legacy systems requiring massive facilities.[1][2][5]
• Production Partnerships: Collaboration with SkyWater Technology for U.S.-based fabrication of digital superconducting controllers accelerates prototype-to-scale transition.[5]
• Proven Team and Funding Momentum: Elite founders from quantum physics, semiconductors, and industry (e.g., Mobileye, Weizmann) back rapid progress from design to lab fab with $35M raised.[4][6]

Role in the Broader Tech Landscape

QuamCore rides the fault-tolerant quantum computing wave, targeting the "1 million qubit" threshold for real-world quantum advantage in drug discovery, optimization, and AI training—trends accelerating as NISQ-era limits expose scaling needs.[2][6] Timing is ideal amid maturing superconducting tech (leading platform per industry consensus) and global pushes for practical QC, with market forces like U.S. foundry demand (via SkyWater) and Israeli innovation ecosystem favoring it.[5][6] By embedding controls cryogenically, QuamCore influences the ecosystem by redefining viability: reducing cryo infrastructure costs enables broader adoption, pressuring competitors like IBM/Rigetti to match compactness, and positioning superconductors ahead of rivals like ion traps.[3][4]

Quick Take & Future Outlook

QuamCore's near-term focus is fabricating first-gen processors, integrating prototypes in a dedicated lab, and scaling to million-qubit demos, leveraging $35M for 2026 milestones.[5][6] Trends like cryogenic CMOS advances and error-corrected QC will propel it, potentially unlocking pharma/AI breakthroughs by 2028 if fab succeeds. Its influence could evolve from hardware innovator to ecosystem enabler, licensing architecture or partnering with hyperscalers—cementing Israel's quantum edge while proving scalable QC is no longer theoretical, directly tackling the bottleneck CEO Cohen identified at founding.[2][6]